Graphene-enhanced G1 Wonder mask - hands on review

India-based Nanomatrix Materials (NM Materials) produces graphene-oxide materials and derivatives (such as r-GO) at its 20Kg/month GO plant, and the company recently launched its own brand of graphene-enhanced face mask, the G1 Wonder mask.

A few weeks ago, NM Materials sent us a couple of masks for a review here at Graphene-Info, and this short review will summarize our findings.

LiGC's laser-induced graphene filter based virus filter is now available for pre-order

Israel-based laser-induced graphene developer LIGC Application announced that its ViralWall air-purifier is now available for pre-order. The ViralWall costs $279, and will ship in April. Graphene-Info users can enjoy a 10% discount, just use this link to order and make sure to enter the discount code (graphene-info) when you checkout.

Using a graphene-based filter, the ViralWall "cleans the air from airborne bacteria and viruses and creates an invisible 1.2x1.6 meter air screen between people to prevent the spread of harmful airborne particles".

Zen Graphene Solutions and TreborRx announce nitrile glove agreement

Zen Graphene Solutions logo imageZen Graphene Solutions has announced an agreement reached on January 16th with TreborRx (Trebor) for application of its graphene-based coating on nitrile gloves sourced or produced by Trebor.

ZEN will provide Trebor with a distribution agreement for Canada, the USA and Mexico. Trebor agrees to use the coating on all gloves sold and will pay ZEN a royalty per glove coated, with a minimum first year guarantee of 100 million gloves.

Cardea Bio Adds $6.5 Million to its Series A fundraises

Cardea Bio, Inc., U.S-based manufacturer of a biology-enabled transistor technology made from graphene-based biosensors, recently raised $6.5 Million in a series A extension that brings its A round total above $20M.

The new capital infusion is led by the life sciences and biotechnology focused investor 3E Bioventures Capital and joined by existing investors. Proceeds from the financing will be used to further develop Cardea’s proprietary Transistor platform, in order to significantly expand mass-manufacturing and further grow Cardea’s number of commercial partnerships.

Zen Graphene Solutions develops graphene-based potential treatment for bacterial and viral Infections

Zen Graphene Solutions logo imageZEN Graphene Solutions has announced that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound.

Recent testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto are said to indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including upper and lower respiratory tract infections - where COVID-19 is a major contributor - as well as drug resistant organisms.